Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy

OBJECTIVE: To evaluate the efficiency of resources allocation and sustainability of the use of netupitant+palonosetron (NEPA) for chemotherapy-induced nausea and vomiting (CINV) prophylaxis assuming the Italian National Health Service (NHS) perspective. A published Markov model was adapted to assess...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Restelli, Umberto, Saibene, Gabriella, Nardulli, Patrizia, Di Turi, Roberta, Bonizzoni, Erminio, Scolari, Francesca, Perrone, Tania, Croce, Davide, Celio, Luigi
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2017
Soggetti:
Health Economics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642784/
https://ncbi.nlm.nih.gov/pubmed/28765126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-015645
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi